Quantification of Influenza A Virus Titer
Corresponding Organization : Polpharma Biologics (Netherlands)
Variable analysis
- Dilution of purified influenza A/PR/8/34 (PR/8) virus
- Viral titer determined by plaque forming assay using MDCK cells
- MDCK cell monolayers seeded at 1x10^6 cells/well and grown overnight
- DMEM (Sigma) medium supplemented with 10% fetal calf serum (FCS; Sigma), 100 U/ml penicillin and 100 μg/ml streptomycin
- Overlay medium consisting of DMEM with antibiotics, 0.005% DEAE-Dextran (Sigma), 0.2% endotoxin-free bovine serum albumin (Fisher Scientific), 0.2% TPCK-treated trypsin (Sigma) and 1% agarose (Biozym)
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!